DE2024251C3 - Verfahren zur Isolierung eines fibrinolytischen Enzyms und dieses Enzym - Google Patents
Verfahren zur Isolierung eines fibrinolytischen Enzyms und dieses EnzymInfo
- Publication number
- DE2024251C3 DE2024251C3 DE2024251A DE2024251A DE2024251C3 DE 2024251 C3 DE2024251 C3 DE 2024251C3 DE 2024251 A DE2024251 A DE 2024251A DE 2024251 A DE2024251 A DE 2024251A DE 2024251 C3 DE2024251 C3 DE 2024251C3
- Authority
- DE
- Germany
- Prior art keywords
- active ingredient
- sephadex
- protease
- deae
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 16
- 102000004190 Enzymes Human genes 0.000 title claims description 11
- 108090000790 Enzymes Proteins 0.000 title claims description 11
- 101710196208 Fibrinolytic enzyme Proteins 0.000 title claims 2
- 108091005804 Peptidases Proteins 0.000 claims description 37
- 239000004365 Protease Substances 0.000 claims description 33
- 239000004480 active ingredient Substances 0.000 claims description 32
- 229920005654 Sephadex Polymers 0.000 claims description 18
- 239000012507 Sephadex™ Substances 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 15
- 239000000872 buffer Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 241000122824 Aspergillus ochraceus Species 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 150000001450 anions Chemical class 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- 238000005227 gel permeation chromatography Methods 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 2
- 239000005695 Ammonium acetate Substances 0.000 claims description 2
- 229940043376 ammonium acetate Drugs 0.000 claims description 2
- 235000019257 ammonium acetate Nutrition 0.000 claims description 2
- 239000012062 aqueous buffer Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 102000035195 Peptidases Human genes 0.000 description 35
- 235000019419 proteases Nutrition 0.000 description 23
- 230000000694 effects Effects 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 230000002797 proteolythic effect Effects 0.000 description 8
- 238000002955 isolation Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 230000003480 fibrinolytic effect Effects 0.000 description 6
- 241000228212 Aspergillus Species 0.000 description 5
- 240000006439 Aspergillus oryzae Species 0.000 description 5
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 5
- 239000003527 fibrinolytic agent Substances 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 239000013543 active substance Substances 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 230000004962 physiological condition Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 241000293029 Absidia caerulea Species 0.000 description 2
- 241001513093 Aspergillus awamori Species 0.000 description 2
- 241000228197 Aspergillus flavus Species 0.000 description 2
- 108091005658 Basic proteases Proteins 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 206010047249 Venous thrombosis Diseases 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229960001322 trypsin Drugs 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 241000235389 Absidia Species 0.000 description 1
- 208000031104 Arterial Occlusive disease Diseases 0.000 description 1
- 206010003880 Axillary vein thrombosis Diseases 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010014513 Embolism arterial Diseases 0.000 description 1
- 101710089384 Extracellular protease Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 206010048591 Post thrombotic syndrome Diseases 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 108010051873 alkaline protease Proteins 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- FIVPIPIDMRVLAY-UHFFFAOYSA-N aspergillin Natural products C1C2=CC=CC(O)C2N2C1(SS1)C(=O)N(C)C1(CO)C2=O FIVPIPIDMRVLAY-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- QCUOBSQYDGUHHT-UHFFFAOYSA-L cadmium sulfate Chemical compound [Cd+2].[O-]S([O-])(=O)=O QCUOBSQYDGUHHT-UHFFFAOYSA-L 0.000 description 1
- 229910000331 cadmium sulfate Inorganic materials 0.000 description 1
- 230000000963 caseinolytic effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- FIVPIPIDMRVLAY-RBJBARPLSA-N gliotoxin Chemical compound C1C2=CC=C[C@H](O)[C@H]2N2[C@]1(SS1)C(=O)N(C)[C@@]1(CO)C2=O FIVPIPIDMRVLAY-RBJBARPLSA-N 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005202 streptokinase Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
- C12N9/62—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from Aspergillus
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/01—General aspects dealing with the joint area or with the area to be joined
- B29C66/05—Particular design of joint configurations
- B29C66/10—Particular design of joint configurations particular design of the joint cross-sections
- B29C66/11—Joint cross-sections comprising a single joint-segment, i.e. one of the parts to be joined comprising a single joint-segment in the joint cross-section
- B29C66/112—Single lapped joints
- B29C66/1122—Single lap to lap joints, i.e. overlap joints
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DD14036369 | 1969-06-09 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2024251A1 DE2024251A1 (de) | 1971-02-11 |
| DE2024251B2 DE2024251B2 (de) | 1979-08-02 |
| DE2024251C3 true DE2024251C3 (de) | 1980-04-03 |
Family
ID=5481312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2024251A Expired DE2024251C3 (de) | 1969-06-09 | 1970-05-19 | Verfahren zur Isolierung eines fibrinolytischen Enzyms und dieses Enzym |
Country Status (9)
| Country | Link |
|---|---|
| AT (1) | AT296195B (enrdf_load_stackoverflow) |
| CS (1) | CS151021B2 (enrdf_load_stackoverflow) |
| DE (1) | DE2024251C3 (enrdf_load_stackoverflow) |
| DK (1) | DK130005B (enrdf_load_stackoverflow) |
| FR (1) | FR2047889A1 (enrdf_load_stackoverflow) |
| HU (1) | HU163467B (enrdf_load_stackoverflow) |
| RO (1) | RO57948A (enrdf_load_stackoverflow) |
| SE (1) | SE378602B (enrdf_load_stackoverflow) |
| SU (1) | SU375829A3 (enrdf_load_stackoverflow) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2468081C2 (ru) * | 2011-03-09 | 2012-11-27 | Александр Андреевич Осмоловский | Способ получения протеиназы - активатора протеина с плазмы крови |
| RU2448158C1 (ru) * | 2011-03-24 | 2012-04-20 | Эспосито Трейдинг Лтд | Способ получения препарата фортелизин, обладающего фибринолитическими свойствами, и его применение для лечения инфаркта миокарда |
-
1970
- 1970-01-08 FR FR7000610A patent/FR2047889A1/fr active Granted
- 1970-05-19 DE DE2024251A patent/DE2024251C3/de not_active Expired
- 1970-05-20 AT AT04523/70A patent/AT296195B/de not_active IP Right Cessation
- 1970-06-02 CS CS3851A patent/CS151021B2/cs unknown
- 1970-06-04 DK DK289370AA patent/DK130005B/da unknown
- 1970-06-08 HU HUAE320A patent/HU163467B/hu unknown
- 1970-06-08 SU SU1447197A patent/SU375829A3/ru active
- 1970-06-09 RO RO63586A patent/RO57948A/ro unknown
- 1970-06-09 SE SE7007982A patent/SE378602B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RO57948A (enrdf_load_stackoverflow) | 1975-06-15 |
| SE378602B (enrdf_load_stackoverflow) | 1975-09-08 |
| AT296195B (de) | 1972-01-15 |
| CS151021B2 (enrdf_load_stackoverflow) | 1973-09-17 |
| FR2047889B1 (enrdf_load_stackoverflow) | 1974-04-12 |
| DK130005B (da) | 1974-12-09 |
| SU375829A3 (enrdf_load_stackoverflow) | 1973-03-23 |
| DK130005C (enrdf_load_stackoverflow) | 1975-06-09 |
| DE2024251A1 (de) | 1971-02-11 |
| DE2024251B2 (de) | 1979-08-02 |
| HU163467B (enrdf_load_stackoverflow) | 1973-09-27 |
| FR2047889A1 (en) | 1971-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0209061B1 (de) | Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel | |
| EP0181465B1 (de) | Blutgerinnungshemmende Proteine, Verfahren zur Herstellung sowie deren Verwendung | |
| EP0480906B1 (de) | Pharmazeutische Zubereitung auf Basis von Lys-Plasminogen | |
| DE3032488C2 (enrdf_load_stackoverflow) | ||
| DE3402647A1 (de) | Verfahren zur gewinnung von koloniestimulierendem faktor und kallikrein aus menschlichem urin | |
| DE2459915C3 (de) | Aktive Verbindung des Plasminogen- Typs, Verfahren zu ihrer Reinigung und ihre Verwendung | |
| DE2218148A1 (de) | Entzündungshemmendes Mittel und Ver fahren zur Herstellung desselben | |
| DE2024251C3 (de) | Verfahren zur Isolierung eines fibrinolytischen Enzyms und dieses Enzym | |
| DE3806423C2 (de) | Verfahren zur Herstellung von Pectin | |
| DE3678749D1 (de) | Verwendung von pollenextrakten zur herstellung von pharmazeutischen praeparaten zur prophylaktischen behandlung von allergien. | |
| DE3306944C2 (enrdf_load_stackoverflow) | ||
| DE2605576C3 (de) | Verfahren zum Isolieren der Proteasen Papain,,Chimopapain, Lysozym und Proteinase X aus dem Milchsaft von Carica papya und Verwendung der isolierten Proteasen zur Herstellung von sterilisierten und Iyophilisirten orthopädischen, neurochirurgischen oder ophthalmologischen Präparaten | |
| US4330528A (en) | Drug for stimulating the rate of proliferation of liver cells and method for producing same | |
| DE3586952T2 (de) | Fibrinophiler urokinase-komplex und dessen herstellung. | |
| DE2047317C3 (de) | Verfahren zur Herstellung einer Protease mit der Bezeichnung AM-Protease aus dem Pilz Armiüaria mellea, diese Protease selbst und sie enthaltende pharmazeutische Stoffzusammensetzungen | |
| US4908206A (en) | Extracts of embryonic organs, process for their preparation and pharmaceutical preparation containing them | |
| DE2508396A1 (de) | Verfahren zur gewinnung von virusproteinen, die dabei erhaltenen proteine und diese proteine als wirkstoffe enthaltende arzneimittel | |
| DE2806181C2 (de) | Polysaccharid, Verfahren zu dessen Herstellung und Arzneimittel, das dieses Polysaccharid enthält | |
| DE69230887T2 (de) | Escharase enthaltene proteolytische mischung und methode seiner isolierung | |
| US3549610A (en) | Method of collecting protein substances having biological activity with respect to the nervous system comprising extraction of protein from submaxillary glands with ammonium sulfate or sodium sulfate | |
| DE69012958T2 (de) | Fibrinolytisches Protein und Herstellungsweise dafür. | |
| AT392003B (de) | Verfahren zur herstellung eines insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes aus saeugetierblut durch papainhydrolyse und ein einen solchen wirkstoff enthaltendes praeparat | |
| JPS60197626A (ja) | 血圧降下剤 | |
| DE2210262A1 (de) | Polyvalente proteaseninhibitorpraeparate aus helix pomatia | |
| AT330953B (de) | Verfahren zur herstellung eines pharmazeutischen praparates zur verbesserung der zellatmung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| 8330 | Complete disclaimer |